4 ms·
It's not clear in the OP, but according to the complaint, the test that the plaintiff underwent was the finger prick method: > 76. Theranos drew blood from R.C
by danso 10y ago
It's not clear in the OP, but according to the complaint, the test that the plaintiff underwent was the finger prick method:
> 76. Theranos drew blood from R.C. using its “tiny drop” finger prick method. The process was painful and was not quick as advertised. The phlebotomist struggled to secure enough blood from R.C.’s finger and had to repeat the painful process several times before collecting enough to test.
IIRC, Theranos did regular type of draws, too, as the finger prick tests weren't performing particularly well. They touted their venous draws as being more efficient and cheaper than the standard tests, though:. From their homepage:
> Our tests, including venous draws, require smaller samples than traditional labs. We also use much smaller needles. Ones designed specifically for collecting blood for children, taking the smallest sample possible. Theranos tests mean less blood, an easier process, and a clear difference in your experience.
- throwanem 10y ago> Our tests, including venous draws, require smaller samples than traditional labs. This seems highly suspect, considering that their venous draws were processed on the same equipment as that used by "traditional labs", following the same procedures as those used by "traditional labs" - or so, at least, have run the company's claims, when they're arguing that only the Edison tests are invalid, and that the non-Edison tests are as reliable as those performed by "traditional labs". I don't see how both sets of claims can be true at once.
- wmil 10y agoNormally nurses draw more than necessary so that the lab can do retests, or do additional tests. Once you're sticking a needle in someones vein the marginal aggravation of taking extra blood is pretty small. So they could probably get away with taking less blood.
- throwanem 10y agoIf that's the difference, it means either: - Theranos' vein-stick patients, in the aggregate, got stuck more often than patients whose bloodwork was processed by other "traditional labs", because their vein stick samples didn't include the usual amount of padding; or - Theranos' "traditional", i.e. non-Edison, results were more than ordinarily bogus, too, because they didn't have enough sample to rerun questionable results and didn't poke another hole in the patient to get more. Neither seems a point in favor.